Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models

Overview of attention for article published in Pharmaceutical Research, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 2,870)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,764 followers.

Sorry about the "mandatory" pre-amble of negativity. But good study and available. https://t.co/s1t2YiSVEd https://t.co/NrYAru8ybN https://t.co/s1t2YiSVEd

Activity of Indatuximab Ravtansine against Triple-Negative #BreastCancer in Preclinical Tumor Models @Biotest_AG https://t.co/AMJvXZgmzg https://t.co/OohTJGxXQf